The Anti-Nectin 4: A Promising Tumor Cells Target. A Systematic Review
Author:
Affiliation:
1. 1Department of Medical Oncology, Lucien Neuwirth Cancer Institute, Saint Priest en Jarez, France.
2. 2Department of Radiotherapy, Lucien Neuwirth Cancer Institute, Saint Priest en Jarez, France.
Abstract
Publisher
American Association for Cancer Research (AACR)
Subject
Cancer Research,Oncology
Link
https://aacrjournals.org/mct/article-pdf/21/4/493/3107738/493.pdf
Reference68 articles.
1. Nectin family of cell-adhesion molecules: structural and molecular aspects of function and specificity;Samanta;Cell Mol Life Sci,2015
2. Chapter six—nectins and nectin-like molecules in development and disease;Mandai;Curr Top Dev Biol,2015
3. Vav2 as a Rac-GDP/GTP exchange factor responsible for the nectin-induced, c-Src- and Cdc42-mediated activation of Rac;Kawakatsu;J Biol Chem,2005
4. Involvement of nectin in inactivation of integrin alpha(v)beta(3) after the establishment of cell–cell adhesion;Sakamoto;J Biol Chem,2008
5. Nectins and nectin-like molecules: roles in contact inhibition of cell movement and proliferation;Takai;Nat Rev Mol Cell Biol,2008
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Future theranostic strategies: emerging ovarian cancer biomarkers to bridge the gap between diagnosis and treatment;Frontiers in Drug Delivery;2024-02-01
2. Expression of PVRL4, a molecular target for cancer treatment, is transcriptionally regulated by FOS;Oncology Reports;2023-12-05
3. Clinical and Biological Differences between Upper Tract Carcinoma and Bladder Urothelial Cancer, Including Implications for Clinical Practice;Cancers;2023-11-23
4. Temporary Tumor Shrinkage Following Enfortumab Vedotin Therapy for Metastatic Urothelial Carcinoma After Radical Cystectomy With Neoadjuvant Chemotherapy: A Case Report;Cureus;2023-08-04
5. Antibody Drug Conjugates in Bladder Cancer: Current Milestones and Future Perspectives;Current Treatment Options in Oncology;2023-07-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3